Literature DB >> 2573662

Stable radioresistance in ataxia-telangiectasia cells containing DNA from normal human cells.

L N Kapp1, R B Painter.   

Abstract

SV40-transformed ataxia-telangiectasia (AT) cells were transfected with a cosmid that contains a normal human DNA library and a selectable marker, the neo gene, which endows successfully transformed mammalian cells with resistance to the antibiotic G418. After a three-part selection protocol for G418 resistance and radioresistance, a cell line stably resistant to ionizing radiation was recovered. Cells from this line were irradiated with 50 Gy of X-rays and fused with non-transfected AT cells. Among the G418-resistant colonies recovered was one that was stably resistant to radiation. Resistance to ionizing radiation of both the primary transfectant line and its fusion derivative was intermediate between that of AT cells and normal cells, as assayed by colony-forming ability and measurement of radiation-induced G2 chromatid aberrations; both cell lines retained AT-like radioresistant DNA synthesis. These results suggest that, because radioresistance in the transfected cells was not as great as that in normal human cells, the two hallmarks of AT, radiosensitivity and radioresistant DNA synthesis, may still be the result of a single defective AT gene.

Entities:  

Mesh:

Year:  1989        PMID: 2573662     DOI: 10.1080/09553008914551891

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  16 in total

1.  Cloning of a candidate gene for ataxia-telangiectasia group D.

Authors:  L N Kapp; R B Painter; L C Yu; N van Loon; C W Richard; M R James; D R Cox; J P Murnane
Journal:  Am J Hum Genet       Date:  1992-07       Impact factor: 11.025

2.  Partial complementation of the Fanconi anemia defect upon transfection by heterologous DNA. Phenotypic dissociation of chromosomal and cellular hypersensitivity to DNA cross-linking agents.

Authors:  C Diatloff-Zito; F Rosselli; J Heddle; E Moustacchi
Journal:  Hum Genet       Date:  1990-12       Impact factor: 4.132

3.  Noncomplementation of radiation-induced chromosome aberrations in ataxia-telangiectasia/ataxia-telangiectasia-variant heterodikaryons.

Authors:  M Stumm; K Sperling; R D Wegner
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

4.  The ATDC (TRIM29) protein binds p53 and antagonizes p53-mediated functions.

Authors:  Zhigang Yuan; Alejandro Villagra; Lirong Peng; Domenico Coppola; Michele Glozak; Eduardo M Sotomayor; Jiandong Chen; William S Lane; Edward Seto
Journal:  Mol Cell Biol       Date:  2010-04-05       Impact factor: 4.272

Review 5.  Regulation of the cell cycle following DNA damage in normal and Ataxia telangiectasia cells.

Authors:  H D Lohrer
Journal:  Experientia       Date:  1996-04-15

6.  TRIM29 functions as a tumor suppressor in nontumorigenic breast cells and invasive ER+ breast cancer.

Authors:  Jin Liu; Bryan Welm; Ken M Boucher; Mark T W Ebbert; Philip S Bernard
Journal:  Am J Pathol       Date:  2011-12-02       Impact factor: 4.307

7.  The product of the ataxia-telangiectasia group D complementing gene, ATDC, interacts with a protein kinase C substrate and inhibitor.

Authors:  P M Brzoska; H Chen; Y Zhu; N A Levin; M H Disatnik; D Mochly-Rosen; J P Murnane; M F Christman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

8.  ATDC/TRIM29 phosphorylation by ATM/MAPKAP kinase 2 mediates radioresistance in pancreatic cancer cells.

Authors:  Lidong Wang; Huibin Yang; Phillip L Palmbos; Gina Ney; Taylor Ann Detzler; Dawn Coleman; Jacob Leflein; Mary Davis; Min Zhang; Wenhua Tang; J Kevin Hicks; Corey M Helchowski; Jayendra Prasad; Theodore S Lawrence; Liang Xu; Xiaochun Yu; Christine E Canman; Mats Ljungman; Diane M Simeone
Journal:  Cancer Res       Date:  2014-01-27       Impact factor: 12.701

9.  Proteomic profiling of human keratinocytes undergoing UVB-induced alternative differentiation reveals TRIpartite Motif Protein 29 as a survival factor.

Authors:  Véronique Bertrand-Vallery; Nathalie Belot; Marc Dieu; Edouard Delaive; Noëlle Ninane; Catherine Demazy; Martine Raes; Michel Salmon; Yves Poumay; Florence Debacq-Chainiaux; Olivier Toussaint
Journal:  PLoS One       Date:  2010-05-03       Impact factor: 3.240

10.  Expression cloning of multiple human cDNAs that complement the phenotypic defects of ataxia-telangiectasia group D fibroblasts.

Authors:  M S Meyn; J M Lu-Kuo; L B Herzing
Journal:  Am J Hum Genet       Date:  1993-12       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.